Working… Menu

A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-tablet Oral Suspension and Gilteritinib Mini-tablets Compared to a Single Dose of Gilteritinib Tablet in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03964038
Recruitment Status : Completed
First Posted : May 28, 2019
Last Update Posted : June 23, 2020
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Global Development, Inc. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2, 2019
Actual Study Completion Date : July 16, 2019